Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple action compounds in angina pectoris.

D T Kelly1, S B Freedman

  • 1Hallstrom Institute of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia.

Zeitschrift Fur Kardiologie
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical interpretation of enteric molecular diagnostic tests.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019
Same author

Relationship between enteric pathogens and acute gastroenteritis disease severity: a prospective cohort study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2018
Same author

Adverse prognosis of incidentally detected ambulatory atrial fibrillation. A cohort study.

Thrombosis and haemostasis·2014
Same author

Drug-induced seizures in children and adolescents presenting for emergency care: current and emerging trends.

Clinical toxicology (Philadelphia, Pa.)·2013
Same author

Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL.

International journal of cardiology·2010
Same author

Four-year follow-up of the Choice of Health Options In prevention of Cardiovascular Events randomized controlled trial.

European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·2010
Same journal

[Not Available].

Zeitschrift fur Kardiologie·2016
Same journal

[Not Available].

Zeitschrift fur Kardiologie·2016
Same journal

[On pathogenesis of coronary heart disease].

Zeitschrift fur Kardiologie·2016
Same journal

An overview of the evolution of the atherosclerotic plaque: from fatty streak to plaque rupture and thrombosis.

Zeitschrift fur Kardiologie·2016
Same journal

[Not Available].

Zeitschrift fur Kardiologie·2016
Same journal

[Reconstructive surgery of the aortic root].

Zeitschrift fur Kardiologie·2016
See all related articles

Carvedilol, a vasodilating beta-blocker, effectively treats angina pectoris by improving exercise tolerance. It offers better outcomes and fewer side effects than traditional beta-blockers and nifedipine, enhancing patient quality of life.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Angina pectoris management often involves beta-blockers or calcium channel blockers.
  • Optimizing anti-anginal therapy is crucial for improving patient outcomes and quality of life.

Purpose of the Study:

  • To evaluate the efficacy and safety of carvedilol in patients with angina pectoris.
  • To compare carvedilol's effectiveness against standard beta-blockers and nifedipine.

Main Methods:

  • Multicenter clinical trials were conducted.
  • Patient exercise tolerance and side effect profiles were assessed.

Main Results:

  • Carvedilol demonstrated comparable efficacy to standard beta-blockers in improving exercise tolerance.
  • Carvedilol showed superior efficacy to nifedipine for angina.

Related Experiment Videos

  • Carvedilol exhibited a more favorable side effect profile than conventional beta-blockers and nifedipine.

    • Conclusions:

    • Carvedilol is an effective anti-anginal therapy.
    • Carvedilol improves exercise tolerance and quality of life in angina patients.
    • Carvedilol presents a favorable safety profile compared to other anti-anginal agents.